Cargando…
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19
BACKGROUND: Cardiovascular complications, including myocardial infarction, ischemic stroke, and pulmonary embolism, represent an important source of adverse outcomes in coronavirus disease-2019 (COVID-19). OBJECTIVES: To assess the frequency of arterial and venous thromboembolic disease, risk factor...
Autores principales: | Piazza, Gregory, Campia, Umberto, Hurwitz, Shelley, Snyder, Julia E., Rizzo, Samantha M., Pfeferman, Mariana B., Morrison, Ruth B., Leiva, Orly, Fanikos, John, Nauffal, Victor, Almarzooq, Zaid, Goldhaber, Samuel Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588178/ https://www.ncbi.nlm.nih.gov/pubmed/33121712 http://dx.doi.org/10.1016/j.jacc.2020.08.070 |
Ejemplares similares
-
THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19
por: Khairani, Candrika, et al.
Publicado: (2021) -
Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19
por: Leiva, Orly, et al.
Publicado: (2021) -
Guidelines and Performance Measures for the Prevention and Treatment of Venous Thromboembolism
por: Fanikos, John
Publicado: (2008) -
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study
por: Bikdeli, Behnood, et al.
Publicado: (2023) -
Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis
por: Leiva, Orly, et al.
Publicado: (2022)